See more : Bank of The Ryukyus, Limited (8399.T) Income Statement Analysis – Financial Results
Complete financial analysis of Bright Health Group, Inc. (BHG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bright Health Group, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- Bayer Aktiengesellschaft (BAYRY) Income Statement Analysis – Financial Results
- Sable Resources Ltd. (SBLRF) Income Statement Analysis – Financial Results
- Tigrent Inc. (TIGE) Income Statement Analysis – Financial Results
- Wistron Information Technology & Services Corporation (4953.TWO) Income Statement Analysis – Financial Results
- KOBO BIOTECH LIMITED (KOBO.BO) Income Statement Analysis – Financial Results
Bright Health Group, Inc. (BHG)
About Bright Health Group, Inc.
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 2.41B | 4.03B | 1.21B | 280.67M | 130.63M |
| Cost of Revenue | 1.28B | 2.21B | 3.95B | 1.05B | 224.39M | 96.41M |
| Gross Profit | -122.92M | 205.79M | 75.72M | 160.02M | 56.29M | 34.23M |
| Gross Profit Ratio | -10.59% | 8.53% | 1.88% | 13.25% | 20.05% | 26.20% |
| Research & Development | 0.00 | 0.00 | 0.00 | 19.43M | 7.24M | 2.54M |
| General & Administrative | 0.00 | 501.84M | 626.36M | 211.75M | 104.22M | 54.48M |
| Selling & Marketing | 0.00 | 82.34M | 287.76M | 96.94M | 49.71M | 26.75M |
| SG&A | 0.00 | 584.18M | 914.11M | 308.69M | 153.93M | 81.23M |
| Other Expenses | 1.74B | 98.28M | 359.76M | 89.50M | 20.45M | 13.09M |
| Operating Expenses | 1.74B | 682.46M | 1.27B | 417.62M | 181.62M | 96.87M |
| Cost & Expenses | 3.02B | 2.89B | 5.23B | 1.46B | 406.01M | 193.27M |
| Interest Income | 0.00 | 12.82M | 7.23M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.20M | 12.82M | 7.96M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 24.17M | 51.36M | 36.71M | 8.29M | 1.13M | 1.03M |
| EBITDA | -1.15B | -425.31M | -1.16B | -249.31M | -124.20M | -61.61M |
| EBITDA Ratio | -98.68% | -17.63% | -28.82% | -20.65% | -44.25% | -47.16% |
| Operating Income | -627.74M | -476.67M | -1.20B | -257.60M | -125.34M | -62.64M |
| Operating Income Ratio | -54.08% | -19.76% | -29.74% | -21.34% | -44.66% | -47.95% |
| Total Other Income/Expenses | -1.43M | -157.61M | -861.96M | -3.80M | 0.00 | 0.00 |
| Income Before Tax | -629.17M | -634.29M | -1.20B | -257.60M | -125.34M | -62.64M |
| Income Before Tax Ratio | -54.20% | -26.30% | -29.90% | -21.34% | -44.66% | -47.95% |
| Income Tax Expense | -1.43M | 3.68M | -26.52M | -9.16M | 8.35M | 3.51M |
| Net Income | -1.20B | -637.97M | -1.18B | -248.44M | -133.69M | -62.64M |
| Net Income Ratio | -103.43% | -26.45% | -29.24% | -20.58% | -47.63% | -47.95% |
| EPS | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EPS Diluted | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| Weighted Avg Shares Out | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
| Weighted Avg Shares Out (Dil) | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
Best Penny Stocks To Buy For March According To Insiders
Bright Health Group, Inc.'s (BHG) CEO Mike Mikan on Q4 2021 Results - Earnings Call Transcript
Bright Health Group Reports Fourth Quarter and Full Year 2021 Results
Bright Health Group to Host Fourth Quarter 2021 Earnings Conference Call on March 2, 2022
Check These Top Penny Stocks Out For Your Watchlist Right Now
Why Bright Health Group's Shares Are Up 29.5% This Week
Are Options Traders Betting on a Big Move in Bright Health Group (BHG) Stock?
Bright Health Group (BHG) Stock: Why The Price Jumped Today
3 Beaten-Down Insurtech Stocks That Could Bounce Back in 2022
Bright Health Group, Inc. (BHG) CEO Mike Mikan on Q3 2021 Results - Earnings Call Transcript
Source: https://incomestatements.info
Category: Stock Reports